| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |